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Space Flight Exposure 
• Space is an inherently hostile environment 
 
• Unique occupational and environmental exposures 
– Microgravity 
– Solar particle events 
– Space radiation 
– Circadian rhythm disruption 
– Psychosocial issues 
– Confined space 
– Altered nutrition 
 
 
 
Effects of Space Flight 
• Acute and chronic effects of space flight 
exposure are not well understood 
– Lack of objective data 
– Limited experience of humans in space 
– Incomplete understanding of physiological effects 
– Variation in medical standards 
 
 
 
Limited Data 
• Only 302 U.S. astronauts have flown in space 
 
• Analysis of rare events and subgroups will have likely have reduced 
statistical power 
– Extravehicular activities (125) 
– Mission length >30 days (45) 
– Walked on moon (12) 
 
• Other data exists 
– Russian space agency (RSA) 
– Japan aerospace exploration agency (JAXA) 
– European space agency (ESA) 
– Others 
 
Sharing Data Across Space Agencies 
• Small, high profile population 
 
• Sharing attributable data may violate individual 
agency policies and international laws 
– Privacy Act of 1974 
– Health Insurance Portability and Accountability 
Act (HIPAA) 
– Federal Law of the Russian Federation No. 152-FZ 
on Personal Data (2006) 
U.S. Department of Health & 
Human Services 
• http://www.hhs.gov/ohrp/international/intlcomp
ilation/hspcompilation-v20101130.pdf 
Meta-Analysis 
• Meta-analytic methods may be used to combine non-
attributable data 
 
• Traditionally used to combine summary measures 
among multiple studies 
– Published 
– Unpublished 
 
• We propose using meta-analytic methods to combine 
summary measures across space agencies 
– Non-attributable data 
– Avoids problems with sharing health related data 
– Unpublished data 
 
Mortality Data (as of July 2009) 
• For example, consider mortality data among 
NASA astronauts with military experience 
 
 
 
• Astronauts exposed to space flight are 0.30 
times less likely to be deceased compared to 
those without space flight experience 
Space Agency Exposure Deceased Living Risk Ratio (95% CI) Variance* 
NASA Space flight 27 199 
No space flight 8 12 0.30 (0.16, 0.57) 0.108 
*Estimated variance of the log-risk ratio 
Russian Space Agency (RSA) 
• How does NASA mortality data compare with 
RSA? 
Space Agency Exposure Deceased Living Risk Ratio (95% CI) Variance* 
NASA Space flight 27 199 
No space flight 8 12 0.30 (0.16, 0.57) 0.108 
RSA Space flight 17 44 
No space flight 29 41 0.67 (0.41, 1.10) 0.063 
*Estimated variance of the log-risk ratio 
Inverse Variance Method 
• Fixed effects method 
– Widely applicable 
– Assumes common effect measure across space 
agencies 
– Differences between observed effect measures 
are due solely to random error 
 
 
Inverse Variance Method 
In our example 
• However, fixed effects methods assume a 
common effect measure. 
Space Agency Risk Ratio (95% CI) Variance* Weight (%) 
NASA 0.30 (0.16, 0.57) 0.108 9.3 (37%) 
RSA 0.67 (0.41, 1.10) 0.063 15.9 (73%) 
Combined 0.50 (0.34, 0.74) 0.199 
*Estimated variance of the log-risk ratio 
Heterogeneity 
In our example 
• This suggests that variation in the effect 
measure may exist between space agencies 
 
Space Agency Risk Ratio (95% CI) Variance* Q (P-value) 
NASA 0.30 (0.16, 0.57) 0.108 
RSA 0.67 (0.41, 1.10) 0.063 
Combined 0.50 (0.34, 0.74) 0.199 3.87 (0.049) 
Alternative Meta-Analytic Methods 
• Therefore, the IV method may not be the best 
option 
– Random effect methods may be more appropriate 
 
• Furthermore, fixed effects methods yield 
suboptimal confidence intervals in the 
presence of heterogeneity and small k 
– Brockwell (2001) 
 
Alternative Meta-Analytic Methods 
Alternative Meta-Analytic Methods 
Applied to Mortality Data 
Method (95% CI) Risk Ratio (95% CI) 
Inverse variance 0 - 0.50 (0.34, 0.74) 
Mantel-Haenszel 0 - 0.54 (0.37, 0.80) 
DerSimonian and Laird 0.245 - 0.46 (0.21, 1.02) 
Sidik 0.245 - 0.46 (0.00, 79.17) 
Profile MLE 0.077 (0.0, 2.8) 0.47 (0.17, 1.20) 
• Using data from additional space agencies 
– Improve estimates 
– Increase generalizability of results 
 
Conclusions 
• Meta-analytic methods provide a practical solution for 
combining data across agencies 
– Only requires non-attributable data 
 
• The profile likelihood method offers the best solution 
for small k 
 
• Measures of association must be clearly and uniformly 
defined 
– Subgroup definitions 
– Outcome measure 
– Interactions 
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